Compare Agilent Technologies Inc (A) vs iShares MSCI Singapore ETF (EWS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs iShares MSCI Singapore ETF — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.00B), while iShares MSCI Singapore ETF trades at $34.04. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares MSCI Singapore ETF pays none, and iShares MSCI Singapore ETF is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | EWS | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $33.92 |
52-Week Low | $110.24 | $26.71 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EWS, the iShares MSCI Singapore ETF, trades at $33.25, up 2.15% today, with a bullish technical signal from moving averages and oscillators. The ETF offers exposure to Singapore's equity market, highlighted by a 3.97% dividend yield and institutional interest, such as Amundi's 4.8% stake increase in Q2 2026. Recent news emphasizes Singapore's economic resilience and AI-driven growth opportunities.
The outlook for EWS is positive due to Singapore's stable economy and sector reforms, but risks include concentrated holdings in financials and regional volatility. Investors may find value in its diversification benefits and dividend consistency, though monitoring economic shifts in Asia is essential for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares MSCI Singapore ETF
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →
